Refractory Metastatic Colorectal Cancer Clinical Trials
0 recruiting
Showing 1–3 of 3 trials
Recruiting
Phase 2
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease
Refractory Metastatic Colorectal Cancer
Delcath Systems Inc.90 enrolled10 locationsNCT06607458
Recruiting
Phase 3
A Phase Ib/III Study of Suvemcitug Plus FTD/TPI in Participants With Refractory Metastatic Colorectal Cancer
Refractory Metastatic Colorectal Cancer
Jiangsu Simcere Pharmaceutical Co., Ltd.464 enrolled6 locationsNCT07361003
Recruiting
Not Applicable
Amplitude Modulated Radiofrequency Electromagnetic Field Treatment Combined With TAS-102 (Lonsurf) and Bevacizumab in Refractory Metastatic Colorectal Cancer
Refractory Metastatic Colorectal Cancer
Charite University, Berlin, Germany12 enrolled1 locationNCT05991102